Patient-led advocacy in ALK-positive lung cancer.

Autor: Barton C; ALK Positive Inc., Atlanta, GA, USA., Al Achkar M; ALK Positive Inc., Atlanta, GA, USA.; Department of Family Medicine, University of Washington, School of Medicine, Seattle, WA, USA., Blender JA; ALK Positive Inc., Atlanta, GA, USA., Farmen SH; ALK Positive Inc., Atlanta, GA, USA., Hall RB; ALK Positive Inc., Atlanta, GA, USA., Konidari AM; ALK Positive Inc., Atlanta, GA, USA., Martinez D; ALK Positive Inc., Atlanta, GA, USA., Pronsati N; ALK Positive Inc., Atlanta, GA, USA., Rosenzweig M; ALK Positive Inc., Atlanta, GA, USA., Vass C; ALK Positive Inc., Atlanta, GA, USA., Venanzi ES; ALK Positive Inc., Atlanta, GA, USA., Westlake W; ALK Positive Inc., Atlanta, GA, USA., Muskavitch MAT; ALK Positive Inc., Atlanta, GA, USA.

Publikováno v: Translational lung cancer research [Transl Lung Cancer Res] 2023 Jun 30; Vol. 12 (6), pp. 1303-1319. Date of Electronic Publication: 2023 Jun 29.